AXNX
Price:
$70.98
Market Cap:
$3.63B
Axonics, Inc. is a medical device firm that focuses on developing and bringing to market sacral neuromodulation (SNM) solutions. These advanced SNM systems are designed to address a range of medical conditions, such as overactive bladder (including urinary urge incontinence and frequent urges to urinate), alongside fecal incontinence and non-obstructive urinary retention. The company's flagship rechargeable SNM System, known as r-SNM, operates by delivering gentle electrical impulses to specific sacral nerves, aiming to restore regular communication between the brain and the bladder or bowel, thereby lessening the symptoms of their dysfunction. Beyond its SNM portfolio, Axonics also provides...[Read more]
Industry
Medical - Devices
IPO Date
2018-10-31
Stock Exchange
NASDAQ
Ticker
AXNX
According to Axonics, Inc.’s latest financial reports and current stock price. The company's current ROE is -1.01%. This represents a change of 325.70% compared to the average of -0.24% of the last 4 quarters.
The mean historical ROE of Axonics, Inc. over the last ten years is -6.39%. The current -1.01% ROE has changed -84.21% with respect to the historical average. Over the past ten years (40 quarters), AXNX's ROE was at its highest in in the June 2023 quarter at 40.07%. The ROE was at its lowest in in the March 2017 quarter at -47.45%.
Average
-6.39%
Median
-13.53%
Minimum
-43.68%
Maximum
35.20%
Discovering the peaks and valleys of Axonics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 92.66%
Maximum Annual ROE = 35.20%
Minimum Annual Increase = -183.38%
Minimum Annual ROE = -43.68%
| Year | ROE | Change |
|---|---|---|
| 2023 | -0.95% | -90.88% |
| 2022 | -10.47% | -36.91% |
| 2021 | -16.60% | -13.15% |
| 2020 | -19.11% | -56.25% |
| 2019 | -43.68% | 92.66% |
| 2018 | -22.67% | -183.38% |
| 2017 | 27.19% | -22.76% |
The current ROE of Axonics, Inc. (AXNX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.34%
5-year avg
-18.16%
10-year avg
-6.39%
Axonics, Inc.’s ROE is greater than 1Life Healthcare, Inc. (-24.31%), greater than CymaBay Therapeutics, Inc. (-64.17%), greater than SpringWorks Therapeutics, Inc. (-35.72%), less than RayzeBio, Inc. Common Stock (82.72%), less than Amedisys, Inc. (9.10%), greater than Inari Medical, Inc. (-0.37%), greater than Olink Holding AB (publ) (-6.93%), greater than Mirati Therapeutics, Inc. (-61.91%), less than NuVasive, Inc. (4.86%), less than Patterson Companies, Inc. (17.54%),
| Company | ROE | Market cap |
|---|---|---|
| -24.31% | $3.40B | |
| -64.17% | $3.73B | |
| -35.72% | $3.54B | |
| 82.72% | $3.75B | |
| 9.10% | $3.32B | |
| -0.37% | $4.68B | |
| -6.93% | $3.24B | |
| -61.91% | $4.12B | |
| 4.86% | $2.08B | |
| 17.54% | $2.77B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Axonics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Axonics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Axonics, Inc.'s ROE?
How is the ROE calculated for Axonics, Inc. (AXNX)?
What is the highest ROE for Axonics, Inc. (AXNX)?
What is the 3-year average ROE for Axonics, Inc. (AXNX)?
What is the 5-year average ROE for Axonics, Inc. (AXNX)?
How does the current ROE for Axonics, Inc. (AXNX) compare to its historical average?